The mRNA vaccine platform may also help cancer research Researchers tested, in cell culture and in mice, a version of the mRNA vaccine technology with an additive called resquimod, which made the treatment more effective than previous attempts to use mRNA vaccines to stimulate the body’s immune system to kill tumors.
Scientists have been developing vaccines to protect against disease for years. Most of these vaccines have been prophylactic, meaning they…
